SCHEMBL31338775

SCHEMBL31338775

Cc1ccc(C)n1-c1cc(Cl)cc(Cl)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 3/20 0.35
NR4A1 P22736 2/20 0.35
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HTT P42858 1/20 0.33
GRM5 P41594 1/20 0.33
GAA P10253 1/20 0.32
HPGD P15428 1/20 0.32
ALOX12 P18054 1/20 0.32
MPI P34949 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32
POLB P06746 1/20 0.32
CTSB P07858 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
LMNA P02545 1/20 0.32
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
RXRG P48443 1/20 0.31
KMT2A Q03164 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29232582 0.84 KDM4E (0.33) MYCNR4A1KDM4EALDH1A1L3MBTL1
SCHEMBL1455672 0.73 HTR3E (0.50) KDM4EALDH1A1L3MBTL1GRM5GAA
SCHEMBL3878600 0.72 HTT (0.44) MYCNR4A1KDM4EALDH1A1HTT
SCHEMBL4648753 0.72 ALDH1A1 (0.39) MYCNR4A1KDM4EALDH1A1L3MBTL1
SCHEMBL17609637 0.72 KDM4E (0.44) KDM4EALDH1A1L3MBTL1GAAHPGD
SCHEMBL19687281 0.72 HTT (0.57) KDM4EL3MBTL1HTTGAALMNA
SCHEMBL21143766 0.72 HTT (0.57) KDM4EL3MBTL1HTTGAALMNA
SCHEMBL19686873 0.71 MAPT (0.53) KDM4EALDH1A1L3MBTL1HTTGAA
SCHEMBL18586369 0.68 KDM4E (0.47) MYCNR4A1KDM4EALDH1A1L3MBTL1
SCHEMBL18618825 0.68 KDM4E (0.36) MYCNR4A1KDM4EALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250171402-A1 Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors UNIV NORTHWESTERN (US) 2025-05-29 US disclosed
US-12240815-B2 Potent and selective human neuronal nitric oxide synthase inhibitors NORTHWESTERN UNIVERSITY (US) 2025-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12240815-B2 Potent and selective human neuronal nitric oxide synthase inhibitors NOS2, NOS1, NOS3 MYC 4084/4885NR4A1 3370/4885KDM4E 2477/4885
US-20250171402-A1 Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors NOS2, NOS1, NOS3 MYC 4084/4885NR4A1 3370/4885KDM4E 2477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.